Revenue: As of FY2025 Q3, the actual value is USD 308.9 M.EPS: As of FY2025 Q3, the actual value is USD 0.42.EBIT: As of FY2025 Q3, the actual value is USD 97.7 M.<h3>Segment Revenue</h3><ul><li>Net Sales - Westlake: $276.5 million for the three months ended September 30, 2025, compared to $215.8 million for the same period in 2024. For the nine months ended September 30, 2025, net sales were $736.4 million compared to $690.5 million in 2024.</li><li>Net Co-products, Ethylene and Other Sales - Third Parties: $32.4 million for the three months ended September 30, 2025, compared to $61.2 million for the same period in 2024. For the nine months ended September 30, 2025, sales were $107.3 million compared to $155.3 million in 2024.</li></ul><h3>Operational Metrics</h3><ul><li>Gross Profit: $99.4 million for the three months ended September 30, 2025, compared to $116.9 million for the same period in 2024. For the nine months ended September 30, 2025, gross profit was $251.0 million compared to $320.4 million in 2024.</li><li>Income from Operations: $92.0 million for the three months ended September 30, 2025, compared to $109.7 million for the same period in 2024. For the nine months ended September 30, 2025, income from operations was $229.8 million compared to $298.4 million in 2024.</li><li>Net Income: $86.2 million for the three months ended September 30, 2025, compared to $104.1 million for the same period in 2024. For the nine months ended September 30, 2025, net income was $214.3 million compared to $281.8 million in 2024.</li></ul><h3>Cash Flow</h3><ul><li>Net Cash Provided by Operating Activities: $160.1 million for the nine months ended September 30, 2025, compared to $352.5 million for the same period in 2024.</li><li>Net Cash Used for Financing Activities: $230.5 million for the nine months ended September 30, 2025, compared to $300.4 million for the same period in 2024.</li></ul><h3>Unique Metrics</h3><ul><li>MLP Distributable Cash Flow: $14.9 million for the three months ended September 30, 2025, compared to $17.9 million for the same period in 2024. For the nine months ended September 30, 2025, MLP distributable cash flow was $34.6 million compared to $51.9 million in 2024.</li><li>EBITDA: $126.1 million for the three months ended September 30, 2025, compared to $139.1 million for the same period in 2024. For the nine months ended September 30, 2025, EBITDA was $325.5 million compared to $386.8 million in 2024.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: The company has renewed the Ethylene Sales Agreement and the Feedstock Supply Agreement through December 31, 2027, which includes automatic 12-month renewal periods. This renewal aligns with the Services and Secondment Agreement and the Omnibus Agreement, ensuring continuity in operations and strategic alignment with Westlake.</li><li>Non-Core Business: No specific plans related to divestitures or emerging segments were mentioned in the report.</li></ul>

Westlake Chemical Partners LP | 10-Q: FY2025 Q3 Revenue: USD 308.9 M